Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Precancerous Conditions 2

Interventions

Cyclophosphamide 415Radiotherapy 274fludarabine 237Gemcitabine 210Cisplatin 202Nivolumab 184pembrolizumab 181Paclitaxel 176Carboplatin 167Magnetic Resonance Spectroscopy 163fludarabine phosphate 156Irinotecan 134Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 122Radiosurgery 117Docetaxel 116Biopsy 115Ipilimumab 114Dexamethasone 113Radiation 109Oxaliplatin 109Fluorouracil 109Etoposide 108Rituximab 107Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Colposcopy × Clear all
NCT06165614 2025-08-19

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
17 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00629577 2017-02-01

SAGE

British Columbia Cancer Agency

Phase 1 Terminated
50 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡